EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)LeserbriefMultizentrische StudieRandomisierte kontrollierte Studie

A randomized trial of ibrutinib and R‐ GDP prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma

John Kuruvilla iD, Christopher Rushton, Diego Villa iD, Muhammad Aslam, Anca Prica iD, Nizar Abdel Samad, Stephane Doucet, Jill Dudebout, Isabelle Fleury, Graeme Fraser, Jean-Francois Larouche, Mona Shafey und 12 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19764 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift British Journal of Haematology, 2024. Verfasst von John Kuruvilla und 23 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Adenine, Lymphoma, Large B-Cell, Diffuse, Piperidines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: Roche Canada, Canadian Cancer Society, Janssen Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenineLymphoma, Large B-Cell, DiffusePiperidinesAdultAgedFemaleHumansMaleMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationPyrazolesPyrimidinesRecurrence

Substanzen

AdenineibrutinibPiperidinesPyrazolesPyrimidines

Autor:innen und Institutionen

  • Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Simon Fraser University, Burnaby, British Columbia, Canada.
  • BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, British Columbia, Canada.
  • Hematology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Hematology, The Moncton Hospital, Moncton, New Brunswick, Canada.
  • Hematologic Oncology, CHUM-Hopital Notre-Dame, Montreal, Quebec, Canada.

ORCID-Profile: John Kuruvilla, Diego Villa, Anca Prica, Michael Crump, Annette E Hay

Förderung

  • Roche Canada
  • Canadian Cancer Society
  • Janssen Research and Development

Zitieren

APA

Kuruvilla, J., Rushton, C., Villa, D., Aslam, M., Prica, A., Abdel Samad, N., Doucet, S., Dudebout, J., Fleury, I., Fraser, G., Larouche, J. F., Shafey, M., Skrabek, P., Skamene, T., Morin, R. D., Alcaide, M., Ben-Neriah, S., Lee, D., Winch, C., …, & Hay, A. E. (2024). A randomized trial of ibrutinib and R‐ GDP prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.19764

Vancouver

Kuruvilla J, Rushton C, Villa D, Aslam M, Prica A, Abdel Samad N, et al. A randomized trial of ibrutinib and R‐ GDP prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma. British Journal of Haematology. 2024. doi:10.1111/bjh.19764

BibTeX
@article{Kuruvilla2024,
  author = {Kuruvilla, John and Rushton, Christopher and Villa, Diego and Aslam, Muhammad and Prica, Anca and Abdel Samad, Nizar and Doucet, Stephane and Dudebout, Jill and Fleury, Isabelle and Fraser, Graeme and Larouche, Jean-Francois and Shafey, Mona and Skrabek, Pamela and Skamene, Tanya and Morin, Ryan D and Alcaide, Miguel and Ben-Neriah, Susana and Lee, David and Winch, Chad and Shepherd, Lois E and Scott, David W and Crump, Michael and Chen, Bingshu E and Hay, Annette E},
  title = {A randomized trial of ibrutinib and R‐ GDP prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19764}
}
Kostenlos starten →